Pure Biologics S.A. (WSE: PUR)
Poland
· Delayed Price · Currency is PLN
17.98
+0.18 (1.01%)
Nov 22, 2024, 5:00 PM CET
Pure Biologics Revenue
Pure Biologics had revenue of 250.00K PLN in the quarter ending September 30, 2024, with 346.43% growth. This brings the company's revenue in the last twelve months to 312.00K, up 294.94% year-over-year. In the year 2023, Pure Biologics had annual revenue of 95.00K, down -85.65%.
Revenue (ttm)
312.00K
Revenue Growth
+294.94%
P/S Ratio
146.15
Revenue / Employee
78.00K
Employees
51
Market Cap
66.39M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.14B |
NEUCA S.A. | 12.34B |
Sopharma AD | 4.35B |
Celon Pharma S.A. | 206.81M |
Synektik Spólka Akcyjna | 624.80M |
Voxel S.A. | 476.19M |
Ryvu Therapeutics S.A. | 91.18M |
Selvita S.A. | 329.02M |